title: The fate of porous hydroxyapatite granules used in facial skeletal augmentation.
abstract: Facial appearance is largely determined by the morphology of the underlying skeleton. Hydroxyapatite is one of several materials available to enhance projection of the facial skeleton. This study evaluated the long-term maintenance of augmented bony projection when porous hydroxyapatite granules are used on the facial skeleton. Ten female patients aged 28-58 years were studied following aesthetic augmentation of the facial skeleton at 24 sites using porous hydroxyapatite granules. Postoperative CT scans at 3 months served as the baseline measurement and compared with scans taken at 1 and 2 years, with the thickness of the hydroxyapatite measured in axial and coronal planes. Thickness of original bone plus overlay of hydroxyapatite, thickness of the overlying soft tissue, and the overall projection (bone plus soft tissue) were recorded. It was found that 99.7% of the hydroxyapatite was maintained at 2 years, with no statistical difference (t test) from the baseline measurement. The overall projection (bony and soft tissue) was maintained as there was no evidence of native bone resorption or soft tissue atrophy. Radiographic results confirmed that the use of porous hydroxyapatite granules for enhancement of the facial skeleton is not only a predictable procedure, but maintains full bony projection at 2 years.
authors.affiliation: Toorak Cosmetic Surgery Centre, 109 Mathoura Road, Toorak, VIC 3142, Australia. bcm@bmendelson.com.au
authors.forename: Bryan C
authors.initials: BC
authors.lastname: Mendelson
authors.forename: Steve R
authors.initials: SR
authors.lastname: Jacobson
authors.forename: Alain M
authors.initials: AM
authors.lastname: Lavoipierre
authors.forename: Richard J
authors.initials: RJ
authors.lastname: Huggins
mesh_terms: D000328:Adult; D001672:Biocompatible Materials / Q000008:administration & dosage*; D003357:Cosmetic Techniques; D005147:Facial Bones / Q000000981:diagnostic imaging; D005260:Female; D006801:Humans; D006882:Hydroxyapatites / Q000008:administration & dosage*; D021621:Imaging, Three-Dimensional; D008875:Middle Aged; D019736:Prostheses and Implants; D014057:Tomography, X-Ray Computed
chemical_list: D001672:Biocompatible Materials; D006882:Hydroxyapatites